Biostax Corp.

BTAX · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$30$150$494$10
Short-Term Investments$0$0$2,645$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$0$0$0$0
Total Curr. Assets$30$150$3,139$10
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$708$763$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$6$51$0$0
Total NC Assets$6$813$0$0
Other Assets$0$0$0$0
Total Assets$35$964$3,139$10
Liabilities
Payables$1,214$1,300$2,185$2,563
Short-Term Debt$1,129$696$3,070$2,845
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,220$1,480$5,832$6,270
Total Curr. Liab.$4,563$3,477$11,087$11,677
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$4,563$3,477$11,087$11,677
Equity
Pref Stock$0$0$0$0
Common Stock$8$8$0$0
Retained Earnings-$385,331-$382,968-$379,432-$383,018
AOCI$0$0$0$0
Other Equity$380,795$380,447$371,484$371,351
Total Equity-$4,528-$2,513-$7,948-$11,667
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$35$964$3,139$10
Net Debt$1,099$546$2,576$2,835